ResearcherUniversity of Yamanashi HospitalActive in the last 2 years
Nobuyuki Enomoto
Matched on ORCID iD 0000-0002-4178-8039; OpenAlex author ID A5103863403. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 8)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 9
- A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population. Last author DOI 10.3390/diagnostics14060651↗
- Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic cancer after pancreatectomy Co-author DOI 10.21203/rs.3.rs-3201226/v1↗
- Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer. Last author DOI 10.1111/cas.15249↗
- Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens. Last author DOI 10.1002/cam4.3723↗
- Digital next-generation sequencing of cell-free DNA for pancreatic cancer. Last author DOI 10.1002/jgh3.12530↗
- Pancreatic cancer secondary to intraductal papillary mucinous neoplasm with collision between gastric cancer and B-cell lymphoma: A case report. Last author DOI 10.12998/wjcc.v9.i10.2400↗
- Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraducta… Last author DOI 10.1097/md.0000000000018039↗
- Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001371↗
- Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer. Last author DOI 10.21037/jgo.2016.06.06↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shinichi Takano · 8 shared papers, 2016–2024 · strength 0.89
- Paper A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population. DOI 10.3390/diagnostics14060651↗
- Paper Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic … DOI 10.21203/rs.3.rs-3201226/v1↗
- Paper Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer. DOI 10.1111/cas.15249↗
- Satoshi Kawakami · 7 shared papers, 2019–2024 · strength 0.83
- Paper A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population. DOI 10.3390/diagnostics14060651↗
- Paper Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic … DOI 10.21203/rs.3.rs-3201226/v1↗
- Paper Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer. DOI 10.1111/cas.15249↗
- Makoto Kadokura · 6 shared papers, 2016–2022 · strength 0.58
- Paper Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer. DOI 10.1111/cas.15249↗
- Paper Digital next-generation sequencing of cell-free DNA for pancreatic cancer. DOI 10.1002/jgh3.12530↗
- Paper Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens. DOI 10.1002/cam4.3723↗
- Hiromichi Kawaida · 3 shared papers, 2019–2023 · strength 0.29
- Paper Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic … DOI 10.21203/rs.3.rs-3201226/v1↗
- Paper Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. DOI 10.1097/mpa.0000000000001371↗
- Paper Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal ad… DOI 10.1097/md.0000000000018039↗
- Hiroshi Kono · 2 shared papers, 2019–2023 · strength 0.22
- Paper Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic … DOI 10.21203/rs.3.rs-3201226/v1↗
- Paper Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. DOI 10.1097/mpa.0000000000001371↗
- Daisuke Ichikawa · 2 shared papers, 2019–2023 · strength 0.22
- Paper Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic … DOI 10.21203/rs.3.rs-3201226/v1↗
- Paper Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. DOI 10.1097/mpa.0000000000001371↗
- Shota Harai · 1 shared paper, 2024 · strength 0.16
- Dai Yoshimura · 1 shared paper, 2024 · strength 0.16
- Ryo Saito · 1 shared paper, 2023 · strength 0.14
- Hideki Fujii · 1 shared paper, 2023 · strength 0.14
- Yuhong Ma · 1 shared paper, 2021 · strength 0.12
- Shintaro Ichikawa · 1 shared paper, 2019 · strength 0.07
- Hiroshi Onishi · 1 shared paper, 2019 · strength 0.07
- Fumitake Amemiya · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.